At Immunofuse we are focused on A New Immunization Modality against Type I Hypersensitivity, Respiratory Viruses, HIV, H. Pylori, Cancer , Ebola, Eosinphilic Esophagitis, Novel and Reinvigorated Antibody Programs, Cancer that enter through the mucosa. Our main focus is the episomal or genomic expression via gene therapy of Dimeric Immunoglobulin A1 (dIgA1) which, becomes secretory immunoglobulin A1 (SIgA1) as part of traversing the epithelium into the mucus. Our gene therapy can work for all including adults of older age and persons with underlying medical conditions because we bypass the adaptive immune system.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.youtube.com/watch
- Keywords
- TotalClarity.
Immunofuse Questions
Immunofuse's website is https://www.youtube.com/watch
Immunofuse's LinkedIn profile is https://www.linkedin.com/company/immunofuse
Immunofuse's industry is
Biotechnology Research
Immunofuse's top competitors are
Virtech Bio,
Telis Bioscience Inc.,
Totalclarity, Inc.,
Neuro3 Therapeutics,
Endotarget,
Imel Biotherapeutics Inc,
Twentyeight-Seven, Inc.,
Theranano Llc,
Manat Bio, Inc.,
Zti Biosciences.
Immunofuse's categories are Biotechnology Research
